| 1 |
McKee PA, Castelli WP, McNamara PM, Kannel WB. The natural history of congestive heart failure: the Framingham study. N Engl J Med 1971;285:1441-1446.
DOI
ScienceOn
|
| 2 |
YooBS, Kim WJ, Kim JY, et al. The clinical experience of B-type natriuretic peptide blood concentrations for diagnosis in congestive heart failure-The single hospital experience based on the large clinical database. Korean Circ J 2004; 34:684-690.
DOI
|
| 3 |
Silver MA, Maisel A, Yancy CW, et al. BNP Consensus Panel. BNP Consensus Panel 2004: A clinical approach for the diagnostic, prognostic, screening, treatment monitoring, and therapeutic roles of natriuretic peptides in cardiovascular diseases. Congest Heart Fail 2004;10:1-30.
|
| 4 |
Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002;347:161-167.
DOI
ScienceOn
|
| 5 |
Tang WH, Girod JP, Lee MJ, et al. Plasma B-type natriuretic peptide levels in ambulatory patients with established chronic symptomatic systolic heart failure. Circulation. 2003;108:2964-2966.
DOI
ScienceOn
|
| 6 |
Bayes-Genis A, Santalo-Bel M, Zapico-Muniz E, et al. N-terminal probrain natriuretic peptide (NT-proBNP) in the emergency diagnosis and in-hospital monitoring of patients with dyspnoea and ventricular dysfunction. Eur J Heart Fail 2004;15:301-308.
|
| 7 |
Gopal DJ, Iqbal MN, Maisel A. Updating the role of natriuretic peptide levels in cardiovascular disease. Postgrad Med 2011;123:102-113.
DOI
ScienceOn
|
webmaster
